Lymphoma,MCL (Mantle Cell Lymphoma) EORTC-Derived Symptom Measures for Lymphoma: A Mixed-Method Feb 22, 2024
Lymphoma,MCL (Mantle Cell Lymphoma) Pirtobrutinib Shows Promising Relief in Resistant MCL Feb 21, 2024
Lymphoma,MCL (Mantle Cell Lymphoma) Burden of Illness in Older MCL Patients: Health Analysis Feb 16, 2024
Lymphoma,MCL (Mantle Cell Lymphoma) Innovative MCL Prognostic Models: Integrative Analysis Feb 07, 2024
CLL (Chronic Lymphocytic Leukemia),Leukemia,Lymphoma,MCL (Mantle Cell Lymphoma) Pirtobrutinib: Continued Efficacy in Post-cbtki CLL/SLL Jan 22, 2024
DLBCL (Diffuse Large B Cell Lymphoma),Lymphoma,MCL (Mantle Cell Lymphoma) Pirtobrutinib Found Safe And Effective In cBTKi Pre‑Treated MCL Nov 03, 2023
DLBCL (Diffuse Large B Cell Lymphoma),FL (Follicular Lymphoma),Lymphoma,MCL (Mantle Cell Lymphoma),MZL (Marginal Zone Lymphoma) Subcutaneous Epcoritamab Is Well-Tolerated And Effective In Patients With R/R LBCL Oct 05, 2023
